Significant Ownership of BVF PARTNERS L P/IL

Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BVF PARTNERS L P/IL.

Notify me when BVF PARTNERS L P/IL files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of BVF PARTNERS L P/IL

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MLTX MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share 28% $141,616,706 19,751,284 BVF PARTNERS L P/IL 06 Nov 2025
IMUX IMMUNIC, INC. Common Stock, $0.0001 par value 10% $8,314,667 +$2,345,708 13,630,601 +39% BVF PARTNERS L P/IL 12 Feb 2026
KYMR Kymera Therapeutics, Inc. Common Stock, $0.0001 par value per share 8.5% $436,311,906 6,867,809 BVF PARTNERS L P/IL 11 Dec 2025
IVA Inventiva S.A. Ordinary Shares, nominal value (euro)0.01 per share 5% $39,714,931 +$4,251,111 9,569,863 +12% BVF PARTNERS L P/IL 17 Nov 2025

Schedules 13D/G Reported by BVF PARTNERS L P/IL:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.